Everything You Need to Know About Beovu Prescribing Information
If you or a loved one has been diagnosed with age-related macular degeneration (AMD), you may have heard of Beovu, a prescription medication that helps slow down the progression of this eye disease. As with any prescription drug, it’s important to understand Beovu’s prescribing information fully. This article serves as a guide to everything you need to know about Beovu prescribing information.
What is Beovu?
Beovu (brolucizumab) is an injection medication used to treat neovascular (wet) age-related macular degeneration. It works by blocking the growth of abnormal blood vessels in the eye. Beovu is administered by a healthcare professional in a medical facility, such as an ophthalmologist’s office.
Who can receive Beovu injections?
Beovu is intended for adults aged 50 years and older who have been diagnosed with neovascular age-related macular degeneration. This type of macular degeneration occurs when abnormal blood vessels grow underneath the retina, causing damage to the macula, which is the part of the eye responsible for central vision.
How is Beovu administered?
Beovu is injected into the eye by a healthcare professional. The injection is given using a small needle, and multiple injections may be necessary to achieve the desired effect. Patients will typically receive the injection once every four to eight weeks, depending on their doctor’s recommendations.
What are the potential side effects of Beovu?
As with any medication, Beovu comes with the risk of side effects. The most commonly reported side effects include blurred vision, eye pain, floaters, and increased eye pressure. In rare cases, more serious side effects may occur, such as retinal artery occlusion or inflammation of the eye.
What should I tell my doctor before receiving Beovu?
It’s important to provide your doctor with a complete medical history before receiving Beovu injections. This includes any medications you are currently taking, as well as any past surgeries or medical conditions. You should also inform your doctor if you are pregnant or planning to become pregnant, as the safety of Beovu during pregnancy is not yet known.
Conclusion
Beovu can be an effective treatment for neovascular age-related macular degeneration, but it’s important to understand its prescribing information fully before deciding whether it’s right for you. By discussing the potential benefits and risks with your healthcare provider, you can make an informed decision about your eye health. Remember to always follow your doctor’s instructions and report any side effects immediately.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)